12/10/2013 9:23:15 AM
Bagsvaerd, Denmark, Dec. 10, 2013 (GLOBE NEWSWIRE) -- As communicated on 31 October 2013 in connection with the release of Novo Nordisk's financial results for the first nine months of 2013, Novo Nordisk's Board of Directors has approved a stock split of the Novo Nordisk B shares listed on NASDAQ OMX Copenhagen and of the American Depositary Receipts (ADRs) listed on New York Stock Exchange (NYSE). The trading unit of the Novo Nordisk B shares listed on the stock exchange in Copenhagen will be changed from DKK 1 to DKK 0.20. The ratio of B shares to ADRs listed on NYSE will remain 1:1. These changes in trading units will take effect as of 2 January 2014 for the Novo Nordisk B shares and as of 9 January 2014 for the ADRs.
Help employers find you! Check out all the jobs and post your resume.
comments powered by